Cartesian Therapeutics | 4:持股变动声明-高管 Kurtoglu Metin
Cartesian Therapeutics | 4:持股变动声明-董事 Singer Michael
Cartesian Therapeutics | 4:持股变动声明-高管 Jewell Christopher M
Cartesian Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Timothy A. Springer(37.1%),TAS Partners LLC(2.2%)等
Cartesian Therapeutics | 4:持股变动声明-董事 SPRINGER TIMOTHY A
Cartesian Therapeutics | 4:持股变动声明-高管 Kurtoglu Metin
Cartesian Therapeutics | 4:持股变动声明-高管 Miljkovic Milos
Cartesian Therapeutics | 4:持股变动声明-高管 Jewell Christopher M
Cartesian Therapeutics | 4:持股变动声明-董事 Kalayoglu Murat
Cartesian Therapeutics | 4:持股变动声明-股东 Hoge Elizabeth
Cartesian Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Murat Kalayoglu(19.9%),Seven One Eight Three Four Irrevocable Trust(17.9%)等
Cartesian Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Timothy A. Springer(37.6%),TAS Partners LLC(2.4%)等
Cartesian Therapeutics | 4:持股变动声明-董事 SPRINGER TIMOTHY A
Cartesian Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Timothy A. Springer(36.7%),TAS Partners LLC(11.7%)等
Cartesian Therapeutics | 4:持股变动声明-董事 SPRINGER TIMOTHY A
Cartesian Therapeutics | 4:持股变动声明-董事 SPRINGER TIMOTHY A
Cartesian Therapeutics | 4:持股变动声明-董事 BARABE TIMOTHY C
Cartesian Therapeutics | SC 13G:超过5%持股股东披露文件-FMR LLC(12.734%),Abigail P. Johnson(12.734%)
Cartesian Therapeutics | D:发行公告
Cartesian Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Invus Public Equities, L.P.(2.8%),Invus Public Equities Advisors, LLC(2.8%)等
暂无数据
暂无数据